What's New on the FDA Drugs Site
May 3, 2016
- Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment Guidance for Industry (PDF - 666KB)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Approval Package: TALTZ (ixekizumab) Injection
- FDA Drug Safety Communication: FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada)
- FDA Drug Safety Podcast: FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy
- FDA Drug Shortages
- Anagrelide Hydrochloride Capsules (Updated - Currently in Shortage)
- Penicillin G Benzathine (Bicillin L-A) Injection (Updated - Currently in Shortage)
- THAM Solution (Tromethamine Injection) (Updated - Currently in Shortage)
- GDUFA Annual Reports and Plans (updated)
- National Drug Code Directory
- Special Protocol Assessment Guidance for Industry (PDF - 640KB)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario